Defects in mitophagy promote redox‐driven metabolic syndrome in the absence of TP53INP1

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|6|802-818

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.6, 2015-06, pp. : 802-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COT phosphorylates prolyl‐isomerase Pin1 to promote tumorigenesis in breast cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. 6, 2015-06 ,pp. : 440-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

By  

EMBO Molecular Medicine, Vol. 1757-4676, Iss. 10, 2015-10 ,pp. : 1350-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

By  

EMBO Molecular Medicine, Vol. 7, Iss. 10, 2015-10 ,pp. : 1350-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite

EB1 acts as an oncogene via activating β‐catenin/TCF pathway to promote cellular growth and inhibit apoptosis

By  

Molecular Carcinogenesis, Vol. 48, Iss. 3, 2009-03 ,pp. : 212-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 159-166

John Wiley & Sons Inc

Access to resources Recommend Favorite